Search Results - "Moschovitis, G"

Individual dosage of digoxin in patients with heart failure by MUZZARELLI, S, STRICKER, H, PFISTER, O, FOGLIA, P, MOSCHOVITIS, G, MOMBELLI, G, BRUNNER-LA ROCCA, H

“…After the publication of DIG trial, the therapeutic target of serum digoxin concentration (SDC) for the treatment of heart failure (HF) has been lowered…”
Get full text

Visualisation of thrombus formation on prosthetic valve by real-time three-dimensional transoesophageal echocardiography by Faletra, F F, Moschovitis, G, Auricchio, A

Get more information

'Bubbles in the brain': systemic air embolism syndrome from an atrial-oesophageal fistula by Cereda, C, Staedler, C, Moschovitis, G, Caronni, F, Bassetti, C L, Azzola, A

Get more information

Impact of atrial fibrillation on cardiac autonomic function in elderly patients by Haemmerle, P, Schier, J, Rizas, K, Schlageter, V, Aeschbacher, S, Krisai, P, Coslovsky, M, Reichlin, T, Moschovitis, G, Conen, D, Sticherling, C, Osswald, S, Bauer, A, Kuehne, M, Meyer-Zurn, C

“…Abstract Introduction Cardiac autonomic dysfunction has been linked to an increased risk of mortality (1), stroke and silent brain lesions (2) and cognitive…”
Get full text

External validation of the new REACT-HF score for heart failure prediction in patients with atrial fibrillation by Moschovitis, G, Rigamonti, E, Wiencierz, A, Coslovsky, M, Blum, S, De Perna, M L, Mayer-Melchiorre, P, Vassalli, G, Pedrazzini, G, Beer, H J, Osswald, S, Healey, J, Conen, D, Kuehne, M, Krisai, P H

“…Abstract Background Heart failure (HF) represents the main cause of hospital admissions and deaths among atrial fibrillation (AF) patients, but precise risk…”
Get full text

Biomarkers for the prediction of cognitive decline in atrial fibrillation patients by Krisai, P, Eberl, M, Coslovsky, M, Rodondi, N, Chocano-Bedoya, P, Kobza, R, Moschovitis, G, Rigamonti, E, Beer, J H, Mueller, A, Reichlin, T, Conen, D, Osswald, S, Bonati, L, Kuehne, M

“…Abstract Background Patients with atrial fibrillation (AF) are at increased risk of cognitive decline. Biomarkers might help to identify the highest risk…”
Get full text

Association between blood pressure and new brain white matter lesions in atrial fibrillation patients by Carmine, D, Aeschbacher, S, Coslovsky, M, Hennings, E, Krisai, P, Rodondi, N, Stauber, A, Mueller, A, Moschovitis, G, Meyer-Zuern, C, Sinnecker, T, Osswald, S, Conen, D, Bonati, L, Kuehne, M

“…Abstract Background Atrial fibrillation (AF) and hypertension (HTN) often occur together. A cross-sectional study in patients with AF has shown that blood…”
Get full text

Association of red cell omega-3 fatty acids, particularly EPA, with cognitive performance in atrial fibrillation by Lee, P, Bosshard, L, Aeschbacher, S, Springer, A, Saeedi, S, Allemann, M, Bonati, L, Kuhne, M, Reichlin, T, Moschovitis, G, Muller, A, Rodondi, N, Conen, D, Osswald, S, Beer, J H

“…Abstract Introduction Atrial fibrillation (AF) is associated with cognitive impairment and dementia. Whether or not omega-3 Fatty Acids (n-3 FAs) have…”
Get full text

Kidney function by creatinine and cystatin c and adverse cardiovascular outcomes in patients with atrial fibrillation by Schweigler, A, Hennings, E, Aeschbacher, S, Rodondi, N, Stauber, A, Moschovitis, G, Bolt, L, Mueller, A, Coslovsky, M, Meyer-Zuern, C, Bonati, L E O H, Conen, D, Osswald, S, Kuehne, M, Krisai, P

“…Abstract Background Atrial fibrillation (AF) patients with chronic kidney disease are at an increased risk for ischemic and bleeding events and all-cause…”
Get full text

Trimethylamine N-oxide is associated with impaired cognitive function in patients with atrial fibrillation by Ziswiler, T, Luciani, M, Vanetta, C, Springer, A, Diteepeng, T, Von Eckardstein, A, Mueller, D, Barbagallo, M, Conen, D, Rodondi, N, Moschovitis, G, Osswald, S, Kuehne, M, Bonati, L H, Beer, J H

“…Abstract Introduction Since patients with atrial fibrillation (AF) are predisposed to suffer from major adverse cerebrovascular events (MACE), they are more…”
Get full text

Web Access to Large Audiovisual Assets Based on User Preferences by Karpouzis, K., Moschovitis, G., Ntalianis, K., Ioannou, S., Kollias, S.

“…Current multimedia databases contain a wealth of information in the form of audiovisual as well as text data. Even though efficient search algorithms have been…”
Get full text

Trimethylamine-N-oxide (TMAO) is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation by Luciani, M, Mueller, D, Vanetta, C, Diteepeng, T, Von Eckardstein, A, Aeschbacher, S, Rodondi, N, Moschovitis, G, Reichlin, T, Bonati, L, Luescher, T.F, Kuehne, M, Osswald, S, Conen, D, Beer, J.H

“…Abstract Introduction Trimethylamine-N-oxide (TMAO) is a well characterized pro-atherogenic metabolite derived from the microbial processing of…”
Get full text

Diabetes is associated with atrial fibrillation phenotype, cardiac and neurological comorbidities: insights from the Swiss-AF study by Bano, A, Rodondi, N, Beer, J, Moschovitis, G, Kobza, R, Aeschbacher, S, Baretella, O, Muka, T, Stettler, C, Franco, O, Conte, G, Sticherling, C, Zuern, C, Conen, D, Reichlin, T

“…Abstract Background Diabetes mellitus is a major risk factor for atrial fibrillation (AF). However, it remains unclear whether individual AF phenotype and…”
Get full text

Brain lesions and cognitive decline in patients with atrial fibrillation by Hennings, E, Bhend, K, Paladini, R E, Aeschbacher, S, Coslovsky, M, Rodondi, N, Beer, J H, Auricchio, A, Moschovitis, G, Chocano, P, Sinnecker, T, Conen, D, Kuehne, M, Bonati, L H, Osswald, S

“…Abstract Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Swiss National Science Foundation, Swiss Heart Foundation…”
Get full text

P1876Atrial fibrillation related symptoms and cardiovascular outcomes by Krisai, P, Blum, S, Aeschbacher, S, Beer, J H, Moschovitis, G, Witassek, F, Kobza, R, Rodondi, N, Mahmood, A, Meyer-Zuern, C, Kuehne, M, Osswald, S, Conen, D

“…Abstract Background Comprehensive information on the impact of atrial fibrillation (AF)-related symptoms and quality of life (QoL) on adverse outcomes is…”
Get full text

Cardiac autonomic function and cognitive performance in patients with atrial fibrillation by Haemmerle, P, Aeschbacher, S, Springer, A, Eken, C, Coslovsky, M, Dutilh, G, Moschovitis, G, Rodondi, N, Chocano, P, Conen, D, Osswald, S, Kuehne, M, Zuern, CS

“…Abstract Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Swiss National Science Foundation OnBehalf Swiss-AF…”
Get full text

Impaired heart rate variability triangular index to identify clinically silent strokes in patients with atrial fibrillation by Haemmerle, P, Eick, C, Bauer, A, Rizas, K.D, Coslovsky, M, Krisai, P, Vesin, J.M, Beer, J, Moschovitis, G, Bonati, L.H, Sticherling, C, Conen, D, Osswald, S, Kuehne, M, Zuern, C.S

“…Abstract Introduction The identification of clinically silent strokes in patients with atrial fibrillation (AF) is of high clinical relevance as they have been…”
Get full text

The Admit-AF risk score: a clinical risk score for predicting hospital admissions in patients with atrial fibrillation by Meyre, P, Aeschbacher, S, Blum, S, Coslovsky, M, Beer, J.H, Moschovitis, G, Rodondi, N, Baretella, O, Kobza, R, Sticherling, C, Bonati, L.H, Schwenkglenks, M, Kuehne, M, Osswald, S, Conen, D

“…Abstract Background Patients with atrial fibrillation (AF) have a high risk of hospital admissions, but there is no validated prediction tool to identify those…”
Get full text

483Blood pressure and white matter lesions in patients with atrial fibrillation by Aeschbacher, S, Blum, S, Meyer-Zurn, C, Vischer, A S, Meyre, P, Rodondi, N, Beer, J H, Moschovitis, G, Moutzouri, E, Sticherling, C M, Wurfel, J, Bonati, L H, Osswald, S, Conen, D, Kuhne, M

“…Abstract Background Hypertension (HTN) is one of the most common cardiovascular risk factors in patients with atrial fibrillation (AF). As a potential risk…”
Get full text

P1898Prevalence and risk of DOACs inappropriate dosing in atrial fibrillation. An analysis of the Swiss-AF and BEAT-AF registries by Montrasio, G, Coslovsky, M, Wiencierz, A, Baumgartner, C, Rodondi, N, Kuehne, M S, Moschovitis, G, Preiss, H, Reiner, M F, De Perna, M L, Conen, D, Osswald, S, Beer, J H, Koepfli, P

“…Abstract Background Direct oral anticoagulants (DOACs) have a similar efficacy in terms of stroke and mortality reduction as compared to Vitamin K-Antagonists…”
Get full text